BrightPath Biotherapeutics Co., Ltd. (TYO:4594)
Japan flag Japan · Delayed Price · Currency is JPY
69.00
+6.00 (9.52%)
Mar 6, 2026, 3:30 PM JST

TYO:4594 Ratios and Metrics

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2018FY 2017
Period Ending
Mar '26 Mar '25 Mar '24 Mar '18 Mar '17
9,0923,9334,56533,67723,373
Market Cap Growth
141.66%-13.84%-86.44%44.09%-
Enterprise Value
7,839-1,301-66929,73519,369
Last Close Price
69.0044.0067.00805.00628.00
PS Ratio
8190.953471.7063409.2795.1344.18
PB Ratio
5.964.254.664.854.50
P/TBV Ratio
5.964.254.664.864.51
EV/Sales Ratio
---84.0036.62
Debt / Equity Ratio
-0.030.12--
Net Debt / Equity Ratio
-0.82-0.85-0.96-0.94-0.95
Net Debt / EBITDA Ratio
--0.824.384.61
Net Debt / FCF Ratio
0.950.630.813.844.25
Asset Turnover
-0.00-0.06-
Inventory Turnover
---9.16-
Quick Ratio
11.986.655.7328.8431.08
Current Ratio
15.768.146.1830.1332.54
Return on Equity (ROE)
--120.92%--25.97%-
Return on Assets (ROA)
--61.73%--15.44%-
Return on Capital Employed (ROCE)
-68.00%-117.40%-111.10%-22.30%-21.20%
Earnings Yield
-11.83%-29.27%-25.59%-4.68%-4.76%
FCF Yield
-14.55%-31.82%-25.48%-5.04%-4.98%
Buyback Yield / Dilution
-127.19%-27.03%-67.81%-12.41%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.